Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
YYForce Highlights US$21.9 Million in Reported Net Assets and Outlines Commercial Robotics and AI Platform Priorities
-
ATLAS ONE CAPITAL CORPORATION ENTERS INTO DEFINITIVE AGREEMENT TO COMPLETE QUALIFYING TRANSACTION WITH RAMSDEN METALS INC.
-
FREELANDER Plans Full Middle East Entry in 2027 and Names Morocco Its Gateway to Africa
-
Five-Seat FREELANDER 8 Makes Its First Appearance at FREELANDER Nightfall
-
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease
-
Kraig Biocraft Laboratories Takes Spider Silk Optimization Beyond Genetics with New Dietary Additive Program
-
Media Advisory: MADD Canada and NSLC Screen New School Program to Educate Students About Impaired Driving
-
Major Drilling Acquires Bunbury Drilling Company, Expanding into Specialized Mine Dewatering in Australia
-
Spectral Medical Inc. Announces Closing of First Tranche of $14.0 Million Convertible Note Private Placement, Conversion of US$4.5 Million of Maturing Convertible Notes and Repayment of US$4.5 Million
-
Rubicon Organics to Report Q3 2026 Results
-
Ewals Cargo Care Brings Its European Logistics Network Into Sync
-
Capital Power reports third quarter 2026 results
-
Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
POET Technologies Names Giovanni Pacelli CFO
-
Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026
-
NorthStrive Acquisition Corp I Announces Business Combination with Nuclea Energy
-
Xtract One Technologies Achieves SOC 2 Type II Certification
-
FLUENT Corp. Announces Proposed Debt Settlement
-
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026
-
Sunday Lake Gold Corp. Appoints New Director
-
American Lithium Increases Macusani Uranium Measured and Indicated Resource
-
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November
-
Conavi Medical Completes First U.S. Commercial Placement and Clinical Cases with its OCTIV™ Hybrid Imaging System to Guide Coronary Interventions
-
Fredonia Confirms Continuity of Gold/Silver Mineralization and the Potential Expansion of the Conceptual EDM Mine Plan at Herradura Hill
-
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
-
Harrow Launches HarrowRx Platform
-
Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
-
Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
-
Tower Semiconductor Reports Third Quarter Record Results, Providing Record Fourth Quarter Guidance Resulting in 2026 $2 Billion Annual Revenue
-
Cipher Digital Provides Third Quarter 2026 Business Update
-
Hinge Bio to Present Latest Results of HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026
-
NorthStrive Acquisition Corp I Announces Business Combination with Nuclea Energy
-
Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
-
SUNation Energy Announces Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Merger with Suniva
-
WRAP Taps Former NYPD Chief Behind Narcan Rollout to Scale BolaWrap and Operationalize De-Escalation
-
Rocket Doctor Expands into Florida, Building Upon Success in California, New York, and Maryland
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
-
Beeline Medicines Initiates First Trial in Lupus Pivotal Development Program with Global Phase 2/3 DISCOVERY Trial of Afimetoran in Cutaneous Lupus Erythematosus (CLE)
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
-
Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Notes,
-
Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference
-
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
-
French Level Up Launches DELF B2 and TCF IRN Readiness Check for Citizenship Applicants
-
Vireo Growth to Report Third Quarter 2026 Financial Results on November 10, 2026
-
Southwestern University and City of Georgetown Officially Begin Construction of Southwestern University 560
-
Lightbridge Provides Business Update and Announces Third Quarter Fiscal 2026 Financial Results
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Alvotech to Present at Upcoming Investor Conferences in November
